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ABSTRACT
The adverse effects of general anesthesia can vary significantly among groups of
individuals. The pediatric population is no exception. Pediatric emergence agitation is a
potential adverse effect observed following emergence from general anesthesia. The
negative impacts from this adverse effect have the potential to decrease patient
satisfaction, increased the cost of care, and increase the risk of post-operative
complications. The exact etiology of pediatric emergence agitation remains unclear;
however, it is thought to be multifactorial (Hoch, 2019). A targeted review of the current
literature suggests a reduction in the incidence of pediatric emergence agitation could be
achieved through alterations in anesthetic techniques. Currently, the literature identifies a
gap existing between evidence-based techniques and actual anesthetic practice (Hoch,
2019).
This project utilized a systemic review of current, evidence-based literature to
develop a best-practice guideline for reducing the incidence of pediatric emergence
agitation. The guideline and supporting literature was presented to a panel of experts in
the field of anesthesia. Panel members were asked to review the guideline and supporting
literature, and offer feedback. Feedback from the panel of experts indicated they were
receptive to the content of contained in the best-practice guideline. Data from the panel of
experts was reviewed and considered in the final draft of this guideline. The final bestpractice guideline was given to members of the panel of experts working at a hospital in
Southeastern Mississippi for use in clinical practice.
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CHAPTER I - INTRODUCTION AND BACKGROUND
The four pillars of general anesthesia include loss of consciousness and amnesia,
analgesia, the abolishment of autonomic reflex responses, and muscle relaxation
(Lerman & JÖhr, 2009). The effects of general anesthesia can vary greatly among
different individuals. Therefore, each anesthetic intervention and technique must be
individually tailored to meet the needs of the current patient being treated. The effects of
general anesthesia on the pediatric population are substantially different in comparison
to the effects seen in adults. Pediatric emergence agitation (EA) is one such effect
routinely observed postoperatively in the pediatric setting following the administration of
general anesthesia (Hoch, 2019). The consequences of this common complication have
the potential to negatively impact the patient’s and their family’s perception concerning
the quality of anesthetic care. Interventions aimed at reducing the risk of pediatric EA
can potentially improve these negative perceptions, as well as lead to increases in patient
satisfaction, and reduced instances of post-operative complications.
Problem Description
Background
Pediatric EA is a common postoperative side effect likely to be experienced by
many patients in the pediatric setting following the administration of general anesthesia
for surgical interventions. According to an article by the American Association of Nurse
Anesthetists (AANA), the postoperative effects of pediatric EA are described as “a state
of mental confusion, agitation, hyperexcitability, crying, restlessness, and hallucinations”
(Hoch, 2019). Risk factors previously identified to correlate with an increased risk of
developing pediatric EA following surgery include children between the ages of 2-5 years
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old, the child’s personality and level of preoperative anxiety, the type and length of
surgery, use of inhalational anesthetics, rapid emergence from anesthesia, and intensity of
postoperative pain (Hoch, 2019). Estimates concerning the incidence of PEA are
approximated to be anywhere from 10%, to as high as 80% (Bajwa et al., 2010).
Significance of Project
Pediatric EA typically occurs approximately 30 minutes following surgery, and
although considered to be a self-limiting complication, the effects can last for up to two
days (Hoch, 2019). The risks associated with pediatric EA are typically benign in
comparison to the more severe risks of general anesthesia such as hypoxia, cerebral
ischemia, and/or death. However, the development of pediatric EA can lead to
complications such as physical injury, removal or dislodgement of drains and catheters,
and interruption of monitoring devices, all of which have the potential to adversely
impact the patient’s health and increase the overall cost of recovery. The effects of these
complications also diminish patient and family satisfaction, as well as their perception of
the quality of care (Hoch, 2019). An opportunity exists for anesthesia providers to
implement interventions aimed at reducing the risk and overall occurrence of pediatric
EA.
Statement of Problem
The effects of pediatric emergence agitation have the potential to lead to
decreased patient and family satisfaction, higher costs of care, and increased
postoperative complications. Ultimately, the current incidence of pediatric emergence
agitation remains elevated due to an existing gap between current evidence-based
literature and actual clinical practice (Hoch, 2019). The goal of the project’s best-practice
2

guideline was to develop a set of recommendations, through a systematic synthesis of
peer-reviewed, evidence-based literature, to reduce the incidence of pediatric EA.
Anesthetic interventions including pharmacological strategies and alterations in
anesthetic methods, techniques, and management were examined and discussed
throughout the entirety of this project.
Available Knowledge
Patient Satisfaction
The Centers for Medicare and Medicaid Services began the development of the
Hospital Consumer Assessment of Healthcare Providers and Systems (HCAHPS) survey
in 2002 (Tevis et al., 2015). The HCAHPS survey is designed to motivate hospitals to
improve quality of care, provide publicly transparent survey results, and allow consumers
to objectively compare hospitals. Hospitals are required to collect a minimum of 300
HCAHPS surveys each year for Inpatient Prospective Payment System. In 2005,
Medicare reimbursement for a hospital has been linked to the hospital’s performance on
the HCAHPS survey (Tevis et al.,, 2015).
Inhalation Anesthetics
Inhalation anesthetics are considered to be the mainstay of general anesthesia. In
the United States, four inhalational anesthetics are approved for use in pediatric
anesthesia: Desflurane, Isoflurane, Sevoflurane, and Nitrous Oxide. These anesthetic
gases provide easy to deliver, effective, and reliable anesthesia (Lerman & JÖhr, 2009).
Inhalational anesthetics provide a means for the practitioner to induce general anesthesia
without intravenous (IV) access. Inhalation induction is accomplished with relative ease,
by having the patient breathe the anesthetic gas via facemask. Inhalation induction is
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largely the most practiced technique for inducing general anesthesia in pediatric
populations (Lerman & JÖhr, 2009).
Sevoflurane is the most commonly used inhalation agent for producing general
anesthesia in the pediatric population. Sevoflurane is preferred for the induction of
pediatric cases due to its non-pungent odor, relatively minimal irritant effect on the
patient’s airway, and the ability to produce a rapid onset and emergence of anesthesia
(Key et al., 2010). These qualities make Sevoflurane an ideal anesthetic gas for
performing an inhalation induction. Mean alveolar concentration (MAC) is used to
express the dose of inhalational anesthetic required to produce surgical anesthesia and
muscular relaxation in 50% of patients when exposed to a noxious stimulus (Nagelhout,
2017b). Monitoring this inhalational anesthetic for the appropriate depth of anesthesia is
accomplished with relative ease and straightforwardness through calculated end-tidal
percentage measurements. These calculations help the anesthetist ensure that adequate
and safe level anesthesia is being delivered by providing real-time measurements taken at
the end of each respiratory cycle. For adult patients, the MAC of Sevoflurane in oxygen
is 2%. In pediatrics, the MAC requirements of Sevoflurane in oxygen can increase up to
3% in infants from six to 12 months of age. After 12 months of age, the MAC
requirement can be slightly reduced, but remains at a higher value compared to the MAC
requirement of adults. (Nagelhout, 2017a). The blood-gas coefficient describes the
proportion of anesthetic gas’s solubility in the blood (Nagelhout, 2017b). Furthermore,
the blood-gas coefficient indicates the speed of uptake and elimination of anesthetic gas.
Agents with lower blood-gas coefficients leave the blood quickly and spread into the
tissues, producing a rapid onset of anesthesia. For example, Isoflurane has one of the
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highest blood-gas coefficients (1.4) producing a slow onset and emergence, while
Desflurane has one of the lowest (0.42) and has a very rapid onset and emergence. The
blood-gas coefficient of Sevoflurane is 0.6, meaning that it produces a rapid induction as
well as a relatively quick emergence (Nagelhout, 2017b). This effect can be particularly
beneficial for many scenarios encountered in pediatrics, especially when the need to
produce a rapid onset of anesthesia is warranted. However, the literature suggests
increased rates of pediatric EA may occur following rapid emergence from general
anesthesia with Sevoflurane. A recently published article examining the emergence
delirium in children states that rapid emergence from Sevoflurane may produce a
dissociative state in pediatric patients, resulting in altered cognition proception,
excitement, and irritability (Locatelli et al., 2013).
Total Intravenous Anesthesia
Total Intravenous Anesthesia (TIVA) describes an anesthetic technique that uses
IV medications to produce a level of surgical anesthesia comparable to that of
inhalational techniques. Recent advancements in technology have made the use of TIVA
more desirable for some pediatric cases. The advantages of TIVA include smooth
emergence from general anesthesia, a reduction in the incidence of postoperative nausea
and vomiting, and rapid onset (Lerman & JÖhr, 2009).
TIVA is typically accomplished through the administration of one or more
combinations of IV medications. Currently, propofol is the most common medication
used in pediatric cases for inducing and maintaining general anesthesia (Lerman & JÖhr,
2009). Propofol’s mechanism of action is through the enhancement of -aminobutyric
acid (GABA) chloride channels. This agonistic effect on GABA receptors produces
5

strong sedative effects that are considered ideal for IV maintenance of general anesthesia.
Currently, the recommended dosage for IV administration of propofol in pediatric
patients is 1-2 milligrams (mg) per kilogram (kg) given as a bolus. Propofol has several
advantages in various settings of anesthesia and is generally associated with a calm,
sometimes euphoric, rapid recovery from general anesthesia (Key et al., 2010).
Anesthetic techniques using propofol TIVA have been shown to decrease the incidence
of pediatric EA. One study compared the quality of recovery in a group of pediatric
patients following inhalational anesthesia with sevoflurane to a group of pediatric
patients following TIVA with propofol. This study found that the rates of pediatric EA
were 46% for patients that received inhalational anesthesia with sevoflurane, and only
9% for patients that received propofol TIVA (Key et al., 2010). Propofol has also been
shown to produce benefits in reducing the incidence of pediatric EA when used as an
adjunct to inhalational anesthesia with sevoflurane. In patients receiving inhalational
anesthesia with sevoflurane, recent evidence suggests administering a 1 mg per kg bolus
dose of propofol at the end of surgery. This method was shown to decrease the incidence
of pediatric EA to 19.5% in patients receiving the bolus dose of propofol compared to
46% in the group of patients to which the bolus dose was not given (Key et al., 2010).
Prophylactic Medications
Preoperative anxiety is considered a factor likely to contribute to the development
of emergence agitation in pediatric patients. Several different medications are typically
used to reduce a patient’s level of anxiety preoperatively with varying success. A detailed
dosage summary of the preoperative medications discussed in this section is provided in
Table 1.
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Table 1.
Preoperative Pediatric Drug Dosages
Drug name

Oral dose

Nasal dose

IM dose

Dexmedetomidine

2-4 mcg/kg

3 mcg/kg

2-4 mcg/kg

Midazolam

0.25-0.75 mg/kg

0.1-0.2 mg/kg

0.1-0.2 mg/kg

Clonidine

4 mcg/kg

Common pediatric preoperative drug dosages (Cote et al., 2019).

Dexmedetomidine is an alpha 2 adrenergic receptor agonist capable of producing
sedative, anxiolytic, and analgesic effects (Mountain et al., 2011). One of the greatest
advantages of using dexmedetomidine is that when compared to similar sedatives,
dexmedetomidine’s effect on respiratory function is minimal. The administration of
dexmedetomidine is not likely to result in extreme hypoxia or hypercapnia (Cote et al.,
2019). The most common side effects of dexmedetomidine include nausea and vomiting,
fever, and bradycardia (Mountain et al., 2011). While the preferred route of
administration continues to be IV, dexmedetomidine can be administered via oral, IM, or
nasal routes as well. Research suggests that when administered preoperatively in oral
doses between 1.0 and 4.2 micrograms (mcg) per kg, dexmedetomidine demonstrated an
ability to produce anxiolysis, decrease the severity of postoperative pain, and reduce the
risk of developing pediatric EA (Mountain et al., 2011). Further research also suggests
that an IV bolus of dexmedetomidine dosed at 0.3 mcg per kg five minutes before
emergence from inhalational anesthesia with sevoflurane significantly reduced the
severity of post-operative pain as well as reduced the incidence of pediatric EA while
observing no adverse effects such as bronchospasm, hypotension, bradycardia, or
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respiratory depression (Guler et al., 2005). Due to variations across several different
studies regarding IV bolus dosing of dexmedetomidine, no clearly defined dosing
consensus has been reached. IV bolus doses of 0.5 mcg/kg and above have been used in
clinical studies, however, it is recommended to avoid doses greater than 0.5 mcg/kg due
to increased incidences of side effects such as hypotension, bradycardia, and delayed
emergence (Begum et al., 2019).
Midazolam is a GABA receptor agonist that causes anterograde amnesia and
anxiolysis following administration. Midazolam is the most common preoperative
medication administered to pediatric patients. Several methods of administration
including oral, intranasal, and IV can be used to provide a preoperative dose of
midazolam. Typically, preoperative doses of midazolam are administered orally in doses
between 0.25 – 0.75 mg/kg (Cote et al., 2019). The most common side effects observed
following administration of midazolam include headache, drowsiness, amnesia, blood
pressure changes, nausea and vomiting, and cough (Mountain et al., 2011). Some studies
suggest a reduction in the incidence of pediatric EA has been demonstrated following the
preoperative administration of midazolam, however, this result is believed to be the result
of a prolonged awakening rather than a reduction in the levels of anxiety (Key et al.,
2010). Although midazolam is considered to be the most commonly administered
preoperative anxiolytic, current evidence suggests that midazolam’s role in the
prevention of pediatric EA is minimal at best. One study demonstrates that the
preoperative administration of midazolam resulted in no clinically significant difference
in pediatric post-operative behavior following general anesthesia with Sevoflurane.
Furthermore, it has been reported that the incidence of pediatric EA in groups of children
8

receiving preoperative doses of Midazolam was nine times higher compared to groups of
children who were not premedicated. In two separate studies, premedication with
midazolam prior to general anesthesia with Sevoflurane produced a pediatric EA
incidence of 38% to 60% (Key et al., 2010).
Clonidine causes dose-related sedative and analgesic effects through an agonistic
effect on alpha 2 receptors (Cote et al., 2019). Research suggests that the use of oral
clonidine as a premedication in the pediatric setting reduced postoperative pain scores
and the need for supplemental analgesics for the first twelve hours following surgery
(Cote et al., 2019). The recommended PO dose of Clonidine for pediatrics is 4mg/kg
(Cote et al., 2019). Pediatric patients preoperatively medicated with Clonidine have been
shown to demonstrate an overall reduction in the development of pediatric EA by 20% to
30% when compared to pediatric patients preoperatively medicated with Midazolam
(Key et al., 2010). Although several benefits are observed with the use of clonidine as a
premedication, the need to administer the medication an hour before anesthetic induction
is largely impractical, especially in busy outpatient settings (Cote et al., 2019).
Existing Guidelines
Current review and research of the literature has not yet identified any single setstandard of guidelines for the prevention of pediatric EA. Primary risk factors thought to
contribute to the development of pediatric EA are multifactorial. Likewise, the treatment
recommendations for the prevention of pediatric EA require a multimodal approach.
Currently, literature provides best-practice recommendations, however, no concrete
guideline has been found to reduce the incidence of pediatric EA. The proposed best-
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practice guideline aims to abridge current best-practice prevention recommendations into
a guideline for a more strategic approach to reducing the incidence of pediatric EA.
Summary of Available Knowledge
Pediatric EA is characterized by acute mental disturbances consisting of
confusion, agitation, hallucinations, and delusions. These disturbances are typically
manifested through inconsolable crying and moaning, restlessness, involuntary
movements, and thrashing around in the bed postoperatively (Key et al., 2010). Issues
resulting from this common complication are known to cause decreases in patient
satisfaction, increased postoperative complications, and increased costs of care. Risk
factors shown to increase the incidence of developing pediatric EA following surgery
include patients between the ages of two and five, increased anxiety preoperatively, type
and length of surgery, use of inhalational anesthetic gases, and the patient’s postoperative pain level (Hoch, 2019). Several efforts to mitigate the risks of developing
pediatric EA have shown some promise, but lack a comprehensive approach to successful
prevention. Studies suggesting the use of propofol TIVA have shown dramatic reductions
in the incidence of pediatric EA. However, the ability to monitor appropriate anesthetic
depth, lack of standardized drug use, and dosage, along with potential patient
interactions, TIVA can be seen as disadvantageous and unsafe by some anesthesia
providers when used as the sole means of achieving surgical anesthesia (Lerman & JÖhr,
2009). Conversely, inhalational anesthesia with sevoflurane provides rapid induction and
emergence, ease of monitoring for appropriate anesthetic depth, and a reliable and proven
means of achieving surgical anesthesia without IV access. However, numerous studies
have indicated that inhalational anesthesia substantially increases the risk of developing
10

pediatric EA. Throughout a review of the literature, evidence suggesting a holistic
guideline shown to eliminate the development of pediatric EA has not been
demonstrated. Risk factors shown to correlate with an increased incidence of developing
pediatric EA have been shown to be multifactorial and thus a multimodal treatment
strategy is likely warranted.
Rationale
Policy Expectations
Through the proper use and implementation of policy, anesthesia providers can
develop better strategies and techniques aimed at reducing the risks of complications, and
improving patient outcomes. Healthcare policy development is aimed at assisting
healthcare providers in achieving an expected standard of care through evidence-based
research (Collins & Patel, 2009). In the area of healthcare effective policy development
requires a multifactorial and multistep approach. A multistep approach involves
identification of a particular issue or problem, analysis of how a particular policy will
address the issue and impact outcomes, standardized development of the proposed policy,
implementing the proposed policy into practice, and an evaluation of how the policy
affected practice (Friedman, 2003). Through the appropriate use of policy, anesthesia
providers can develop better plans and techniques to potentially improve the quality of
patient care and reduce the occurrence of complications.
Theoretical Framework
A conceptual model for effecting provider behavior change was used to guide the
development of this project. In the conceptual model, four phases identify factors
affecting policy implementation. The four phases include exploration, decision to adopt,
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active implementation, and sustainment (Aarons et al., 2011). The conceptual approach
examines the roles that different variables may play during the implementation process of
evidence-based practice guidelines. The exploration phase involves the identification of a
problem or issue that needs a resolution or improvement. The evidence-based bestpractice guideline identifies the primary issue to be frequent occurrences of pediatric EA
due to gaps existing between current knowledge and everyday practice. The decision to
adopt occurs when an individual or organization experiments with new innovations
before broad implementation is initiated. In the evidence-based best-practice guideline,
recommendations were presented, and the panel of experts had the option to institute
changes and/or revisions. During the active implementation phase innovation is more
broadly implemented across platforms, and factors affecting implementation are assessed.
Following feedback from the panel of experts, a final draft of the guideline was
developed. Finally, in the sustainment phase factors were examined to determine the
effectiveness of long-term implementation and maintenance (Aarons et al., 2011).
Triple Aim
The Institute for Healthcare Improvement introduced the Triple Aim in 2008. The
Triple Aim focuses on three specific areas in order to improve healthcare. The areas
included in the collaborative approach are: improving the overall health of a population,
improving the patients’ experience of care, and reducing the cost of healthcare
(Whittington et al., 2015). The Triple Aim requires healthcare organizations to focus on
organizing care in order to meet the health needs of a specific population. Without
attention to the three areas outlined in the Triple Aim, healthcare organizations could
potentially misalign the balance between improving quality of care, and the reduction of
12

healthcare costs (Whittington et al., 2015). Through the use of Triple Aim, the evidencebased best-practice guideline could potentially improve the patient’s experience of care,
while also reducing health care costs.
DNP Essentials
The American Association of Colleges of Nursing (AACN) outlines eight
essential Doctor of Nursing Practice (DNP) competencies deemed fundamental to the
various roles of nurses in the advanced practice setting. All eight essentials outlined by
the AACN were considered in the completion of this doctoral project. However, a
particular emphasis was placed on Essentials III and VIII thought the entirety of this
doctoral project. Essential III (Clinical Scholarship and Analytical Methods for EvidenceBased Practice) describes the use of evidence-based research investigation to guide
advancements in clinical practice. Essential VIII (Advanced Nursing Practice) specifies a
foundation of competencies required for doctoral nursing practice. A complete listing of
DNP essentials outlined by the AACN is listed in Appendix A.
Specific Aims
The purpose of this doctoral project was to develop an evidence-based, bestpractice guideline aimed at reducing the risk of pediatric EA following general anesthesia
in pediatric populations. The best-practice guideline provides anesthesia providers with
the literature reviewed, and evidence-based recommendations regarding anesthetic
techniques and pharmacology use shown to successfully reduce the incidence of pediatric
EA. Pediatric patients that develop pediatric EA have been shown to demonstrate low
levels of patient satisfaction, increased incidence of postoperative complications, and
increased costs of care associated with adverse events arising from pediatric EA. This
13

guideline was developed through the use of evidence-based research regarding best
practice advisories on the prevention of pediatric EA. The guideline was then presented at
The University of Southern Mississippi (USM) to a panel of experts in the field of
anesthesia. The feedback gained from the panel of experts was used to refine areas of the
guideline in order to provide a more strategic means of improving the quality of
anesthetic care. The best-practice guideline has the potential to provide a means of
improving anesthetic care outcomes and patient satisfaction at a hospital in Southeastern
Mississippi.
Summary
Pediatric EA is a relatively common complication following the administration of
general anesthesia in pediatric patients. The incidence is estimated to be anywhere from
10% to 80%, and can likely be attributed to several different factors. Risk factors
commonly associated with the development of pediatric EA include the age of the child,
the child’s current level of anxiety and individual personality, the type and length of
surgery, use of inhalational anesthetics, a rapid emergence from general anesthesia, and
the child’s postoperative pain level (Hoch, 2019). Several of the risk factors previously
mentioned are unable to be altered through anesthetic management. However, through
alterations in the anesthetic technique and approach, several other risk factors could
potentially be minimized. An evidence-based best-practice guideline for reducing the risk
associated with the development of pediatric EA can potentially improve patient
satisfaction, reduce recovery times in PACU, and improve the quality of anesthetic care.
An outline detailing the process and methodology for developing the evidence-based
best-practice guideline is described in Chapter II.
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CHAPTER II - METHODOLOGY
Introduction
The requirements for the DNP project for the USM College of Nursing and
Health Professions include meeting the AACN DNP Essentials. The evidence-based bestpractice guideline for reducing the risk of developing pediatric emergence agitation meets
several DNP essentials outlined by the AACN, with particular focus on DNP Essential III
and DNP Essential VIII. The evidence-based best-practice guideline was submitted to the
USM Institutional Review Board (IRB) for review and approval. IRB approval status
according to protocol is listed in Appendix B (IRB-20-297). Important components
associated with pediatric EA are addressed in the evidence-based best-practice guideline
and warrant attention. These components include: (a) current provider practices, (b)
knowledge of evidence-based literature regarding pediatric EA, and (c) proposed benefits
concerning the acceptance of the evidence-based best-practice guideline.
Context
The evidence-based best-practice guideline is targeted toward anesthesia
providers working in a hospital in Southeastern Mississippi. The hospital’s profit election
is a business corporation (Mississippi Secretary of State, 2014). Currently, the hospital
employs anesthesiologists and Certified Registered Nurse Anesthetists (CRNAs) with
varying years of clinical anesthesia experience. The hospital is also a teaching institution
facilitating the education of medical residents, as well as student nurse anesthetists.
Pediatric surgery cases are performed at the hospital on a weekly basis. The
hospital has approximately 500 inpatient beds and 14 main operating rooms that are
utilized for a variety of both adult and pediatric cases. The pediatric surgical services
15

performed at the hospital include general surgery, ear, nose, and throat surgery, and
dental surgery. The hospital has a history of adhering to quality improvement protocols in
the past, and the anesthesia department has been supportive of the facility’s effort.
Currently, no formal process is in place that would affect the implementation of the
evidence-based best-practice guideline.
Intervention
Recent evidence states that the incidence of pediatric EA is anywhere from 10%
to 80% following the administration of general anesthesia (Bajwa et al., 2010). The
purpose of the evidence-based best-practice guideline is to reduce the risk of pediatric EA
following general anesthesia in pediatric populations. A systematic review of current
evidence-based practice policy concerning the prevention of pediatric EA was performed.
Information gathered from the literature was synthesized and used to guide the formation
of the guideline. A synthesized review of the literature demonstrated a correlation
existing between the development of pediatric EA and lower levels of patient satisfaction,
increased postoperative complications, and increased costs of care associated with
adverse events arising from pediatric EA. The literature also identified a gap between
best practice recommendations and actual anesthesia provider practice (Hoch, 2019). The
guideline provides anesthesia providers with evidence-based best-practice
recommendations that have been shown to reduce the overall incidence of pediatric EA.
A targeted review of evidence-based peer-reviewed literature was accomplished
by using several online research databases: CINHAL, EBSCOhost, MEDLINE, and
PubMed. Primary key search terms included: pediatric anesthesia, pediatric emergence
agitation, dexmedetomidine, midazolam, clonidine, total intravenous anesthesia, volatile
16

anesthetics, and best practice recommendation. Current policies, interventions, and
information concerning pediatric EA, anesthesia provider practice, and guideline
development was compiled and synthesized for use in the production of the evidencebased best-practice guideline. Following the synthesis of data, a panel of experts in the
field of anesthesia was assembled. An email announcement to the panel of experts was
created requesting informed consent for participation. The panel of experts included four
CRNAs currently practicing at a hospital in Southeastern Mississippi, one pediatric
professor at USM NAP, and the DNP project chair. The members of the panel of experts
were chosen based on each member’s advanced knowledge in the field of anesthesia,
particularly as it relates to the area of pediatrics. Upon assembly of the panel of experts, a
survey was composed to obtain critical feedback from the panel. Following the
completion of the survey, approval was sought from the DNP project chair. Once
approval was obtained, the IRB application was submitted for review. After IRB approval
was received, an email containing informed consent, a PowerPoint© presentation
detailing the purposed best-practice guideline, and an anonymous link to the survey was
sent to the panel of experts. Qualtrics© was be used as the anonymous survey tool, and
there were no repercussions for non-participants. Data included in the PowerPoint©
presentation was derived from a review of evidence-based literature on the prevention of
pediatric EA and included information concerning current practice recommendations
from the literature, alternative methods of anesthesia, and pharmacological interventions.
The panel of experts was asked to view the presentation and offer feedback via the
anonymous post-presentation survey. The survey examined the panel’s knowledge of
current literature involving pediatric EA, as well as each panel member’s overall
17

willingness to adopt the proposed recommendations. Data from the survey was then
collected and entered into a summarized table. The data collected was both quantitative
and qualitative, and followed a mixed-methods approach. Quantitative data was
expressed as narrative descriptions, and qualitative data was examined for similarities and
common themes. Following the synthesis of the data, the best-practice guideline was reassessed and refined. Final approval was sought from the DNP project chair. Once final
approval from the DNP project chair was obtained, the best-practice guideline was
presented to the panel of experts working at a hospital in Southeastern Mississippi. The
research was disseminated at USM School of Leadership and Advanced Nursing Practice
Scholarship Day in September of 2020. All electronic data was permanently deleted from
the computer, and the trash file was emptied. The physical data was destroyed by
shredding.
The evidence-based best-practice guideline is aimed at providing the panel of
experts with recommendations supported by peer-reviewed literature which demonstrates
that adoption of the best-practice guideline could potentially decrease the overall
incidence of pediatric EA, potentially resulting in increased patient satisfaction, lower
costs of care, and decreased postoperative complications.
Survey Tool
Data was collected from the panel of experts via an anonymous online survey.
Qualtrics© was used as an anonymous survey tool. A link to the online survey was
emailed to the panel following the PowerPoint presentation of the purposed best-practice
guideline. Participation from the panel of experts was completely voluntary, and the
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panels’ responses to the survey were kept anonymous. There were no consequences or
repercussions for not participating.
Due to the relatively small sample size, data obtained from the survey was not
statistically significant. Data collected from the survey was both quantitative and
qualitative and followed a mixed-methods approach. The quantitative data was examined
and expressed as narrative descriptions. The qualitative data was also examined and
common themes were reported. All data was thoroughly examined and summarized into
table format. All information received from the voluntary participation of the panel of
experts was kept strictly confidential and remained anonymous. Following a review of
data obtained from the survey, final approval of the best-practice guideline was sought
from the DNP project chair. After obtaining DNP chair approval, all information stored
on the computer was permanently deleted, and the trash folder was emptied.
Additionally, all information stored in paper form was destroyed via shredding.
Ethical Considerations
The primary ethical consideration for this project was the inability of individual
providers to adhere to the recommended guideline following approval. If permanently
adopted, the purposed evidence-based best-practice guideline will provide
recommendations for reducing the incidence of pediatric EA. If some individual
providers are unable to follow the recommendations outlined in the purposed guideline,
two standards of pediatric anesthetic care will exist at the facility. Patients cared for by
anesthesia providers that do not adhere to the policy could potentially be at a greater risk
for developing pediatric EA following the administration of general anesthesia.
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Summary
In summary, the purposed evidence-based best-practice guideline is targeted at
reducing the overall incidence of pediatric EA, resulting in increased patient satisfaction,
decreased risk for postoperative complications, and decreased cost of care. A panel of
experts in the field of anesthesia was assembled and presented with a slide-show
presentation outlining the guideline’s recommendations. An anonymous survey link was
distributed among the panel in order to gain valuable feedback concerning the
recommendations listed in the guideline. Panel participation was voluntary, and there
were no repercussions for non-participants. Data gained from the survey was both
quantitative and qualitative, and a mixed-methods approach was used for analysis.
Information from the analysis of data was then evaluated and considered in the final draft
of the evidence-based best-practice guideline. The final draft of the best-practice
guideline was presented to members of the panel of experts currently working at a
hospital in Southeastern Mississippi for use in practice.
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CHAPTER III - RESULTS
Introduction
The effects of pediatric emergence agitation have the potential to lead to
decreased patient and family satisfaction, higher costs of care, and increased incidences
of postoperative complications. Currently, it is believed that the incidence of pediatric
emergence agitation remains elevated due to a gap existing between current evidencebased literature and actual clinical practice. The goal of the project was to develop an
evidence-based best-practice guideline for the prevention of pediatric emergence
agitation. The guideline was synthesized from currently available literature and
disseminated to a panel of experts to review and provide feedback.
Steps of the Intervention
Following the proposed methodology, the project began with a systematic review
of current literature pertaining to the prevention of pediatric EA. Following a review of
the literature, a guideline for the prevention of pediatric EA was constructed. A panel of
experts in the field of anesthesia was then assembled. The panel consisted of four
practicing CRNAs, one pediatric professor, and the DNP chair. Once the panel of experts
was assembled, a PowerPoint© outlining the literature contained in the guideline, along
with an anonymous survey in order to gain feedback from the panel, was created. After
informed consent was obtained, an email was then sent to the panel of experts containing
the letter of informed consent, the PowerPoint©, the proposed best-practice guideline, and
a link to the anonymous survey. The panel of experts was asked to review the material
and offer feedback via the anonymous survey. All responses as well as the identity of the
participants were kept completely anonymous during the entirety of the project. The
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survey consisted of five questions pertaining to the participants' current knowledge of
pediatric EA, willingness to adopt the best-practice guideline as well as any foreseeable
barriers to implementation, and participants’ current practices to prevent pediatric EA.
Additional space was also provided to allow for the participants to provide additional
feedback by means of guideline improvement, personal practices, and additional barriers.
Questions contained in the survey are listed in Appendix C.
Five out of six participants from the panel of experts responded to the survey. The
first question asked participants if the information contained in the presentation was
informative concerning the evidence based risks associated with pediatric emergence
agitation. Five out of five participants responded yes. The second question asked
participants if the contents of the presentation were consistent with doctoral-level work.
Five out of five participants responded yes. Question three asked participants if they used
any additional measures to prevent the incidence of pediatric emergence agitation. Five
out of five participants answered no. The fourth question asked if participants would
consider implementing the purposed best-practice guideline into their practice. Five out
of five participants answered yes. Question five asked participants if they foresaw any
potential barriers to the implementation of the purposed best-practice policy. Four out of
five participants responded no, and one out of five answered yes. The participant
answering yes to question five listed time constraints, current hospital policies, and
individual practitioner’s unwillingness to adopt the proposed guideline as potential
barriers to implementation. The sixth question was qualitative and asked participants to
provide any additional comments or recommendations to the proposed guideline. Two
out of five participants provided additional comments concerning the quality of the
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proposed guideline. None of the participants listed any recommendations concerning
suggestions or improvements to the proposed guideline. Individual responses to the
anonymous survey are listed in Appendix C. Information obtained from the survey was
subsequently reviewed and the panel’s recommendations were considered. No alterations
were made in the final draft of the proposed guideline. The final draft of the guideline
was then provided via email to members of the panel of experts currently practicing at a
hospital in Southeastern Mississippi. Research and data from the project was
disseminated at USM School of Leadership and Advanced Nursing Practice Scholarship
Day in September of 2020. No changes were made from the original steps outlined in
Chapter II.
Details of Process Measures and Outcomes
In summary, an evidenced-based best-practice guideline for the prevention of
pediatric EA was developed in order to decrease the incidence of pediatric EA. The
adverse effects of pediatric EA include decreased patient satisfaction, increased costs of
care, and higher incidences of postoperative complications. The proposed guideline
attempts to bridge a gap between literature recommendations and anesthetic provider
practice by providing practitioners with evidence-based interventions aimed at the
prevention of pediatric EA.
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CHAPTER IV – DISCUSSION
Summary
Pediatric EA is a relatively common complication following the administration of
general anesthesia in pediatric patients. Currently, the incidence of pediatric emergence
agitation remains elevated due to a preexisting gap between current evidence-based
literature and the clinical practice of many anesthesia providers. The evidence-based bestpractice guideline outlined in this project attempts to provide anesthetists with current
practices supported by literature to decrease the prevalence of pediatric emergence EA.
Interpretation
During the review of the literature, a comprehensive guideline outlining
intervention to decrease the incidence of pediatric EA was not found. However, the
literature did identify an existing gap between current recommended practices for the
prevention of pediatric EA, and actual anesthesia provider practice. The proposed
guideline attempts to bridge this gap by providing an evidence-based best-practice
guideline for the prevention of pediatric EA. The proposed guideline was developed and
a panel of experts was asked to review the information and offer feedback. The data
provided from responses to the survey established that the panel of experts were
accepting of the knowledge provided by current literature, and were willing to implement
the practices contained in the guideline. Responses also established that several
participants routinely implement interventions from the guideline into their clinical
practice. However, the specific interventions were not made explicit by the participants.
Implementation of the proposed guideline into clinical practice has the potential to
decrease the prevalence of pediatric EA by providing anesthetists with evidence-based
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knowledge concerning current practices shown to decrease incidences of pediatric EA.
Decreasing the incidence of pediatric EA could potentially lead to higher patient
satisfaction scores, decreased costs of care, and fewer post-operative complications.
Limitation
Limitations of the project are inflated by the relatively small sample of five
respondents. However, efforts were made to optimize the quality of data collected by
focus focusing on the selection quality for the panel of experts. Members of the panel of
experts consisted of clinical practitioners of pediatric anesthesia, published authors of
peer-reviewed research, and professors of nurse anesthesia. The number of questions
contained in the survey was also limited with respect to time, in order to encourage more
meaningful responses. Questions were targeted and to collect the data needed for the
project. For future studies, increasing the sample size of the project could offer a wider
range of feedback for the development of the project’s guidelines. Also, the inclusion of
non-pharmacologic interventions and alternative methods of prevention could provide
anesthetists with a wider range of available strategies to implement into clinical practice.
Conclusions
The proposed guideline was presented to a panel of experts for review. Following
a review of the proposed guideline, the panel of experts was asked to provide feedback
via an anonymous survey. Data gathered from participants’ responses to the survey was
collected over a period of one week. Feedback suggested the panel of experts had a
willingness to incorporate the guideline into clinical practice. The literature outlined in
the project, along with data obtained from the survey was used to develop the guideline
for the prevention of pediatric EA. The proposed guideline could be used to limit the
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adverse effects and consequences resulting from pediatric EA. As one participant
suggested, barriers to implementation affecting the overall sustainability of the proposed
guideline could be influenced by factors such as the cost of medications, current provider
practice, and time constraints. However, the proposed guideline could potentially filter
into other contexts within the area of healthcare. The proposed guideline could be used as
a basis to develop an Objective Structured Clinical Examination (OSCE) to be used in a
pediatric anesthesia course. Because the proposed guideline is not specific to CRNAs and
can apply to all anesthesia providers, hospital administration could also use information
from the project as a means for continuing education for anesthesia providers. Further
recommendations for the ongoing research into decreasing the incidence of pediatric EA
should include a more comprehensive approach using alternative modalities to
pharmacologic interventions. Additional recommendations for further research could
include the development of an OSCE and identification of barriers to implementation.
The advancement of knowledge and continual research into pediatric EA is vital in order
to develop effective prevention strategies and increase the overall quality of anesthetic
care in the pediatric population.
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APPENDIX A – DNP Essentials
Doctor of Nursing Essential
Essential One: Scientific Underpinnings
for Practice

Essential Two: Organizational and
Systems Leadership for Quality
Improvement and Systems Thinking

Essential Three: Clinical Scholarship and
Analytical Methods for Evidence-Based
Practice

Essential Four: Information
Systems/Technology and Patient Care
Technology for the Improvement and
Transformation of Health Care
Essential Five: Healthcare Policy for
Advocacy in Health Care

Essential Six: Interprofessional
Collaboration for Improving Patient and
Population Health Outcomes

How the Essential is Achieved
This doctoral project applied an in-depth
review of evidenced-based literature to
identify best practices supporting the use
of preemptive treatments in the reduction
of POST. The recommendations offered
in this project are founded upon the
findings of scientific works.
This doctoral project aimed to improve
quality through policy recommendations
to a team of experts that would review the
recommendations, disseminate the
information, and provide feedback that
could lead to policy implementation.
This doctoral project used analytical
methods during a targeted review of the
literature to appraise the best practices
available to be included in the
development of a policy recommendation
to a team of experts.
This essential is met through the
development and implementation of a
questionnaire to evaluate the anesthesia
providers use and knowledge of
preemptive treatments for POST
This essential is met through the
identification of a patient care area that
lacks a policy. This project could foster
the implementation of a new policy and
improve the quality of anesthesia care.
This doctoral project utilized professional
communication and collaboration among
anesthesia experts to develop and
implement a change in the healthcare
system.
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Essential Seven: Clinical Prevention and
Population Health for Improving the
Nation’s Health

Essential Eight: Advanced Nursing
Practice

The goal of this project was to improve
the outcomes and perioperative
experiences of patients via the
propagation of the evidenced-based
practices described in this project for
possible future implementation.
This essential is met through the appraisal
of current scientific literature, the delivery
of a presentation regarding contemporary
practice recommendations, and the
collaboration of health professionals to
work towards the implementation of new
healthcare policy.
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APPENDIX B – IRB Approval Letter
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APPENDIX C – Survey Questions
Survey Questions
1.) Was this presentation informative concerning the evidence-based incidence and
risks associated with pediatric emergence agitation?
o Yes
o No

2.) In your opinion, is the information in this presentation consistent with doctorallevel work?
o Yes
o No

3.) Do you take any additional measures to prevent the incidence of pediatric
emergence agitation? (If Yes, please state what additional measures you take)
o Yes
o No
___________________________________________________________________

4.) Would you consider implementing the best-practice guideline from the presentation
into your practice?
o Yes
o No

5.) Do you foresee any potential barriers to the implementation of this best practice
guideline? (If Yes, please briefly describe)
o Yes
o No
__________________________________________________________________

6.) Please provide any additional comments regarding suggestions, improvements, or
recommendations to this guideline.
_____________________________________________________________________
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APPENDIX D – Survey Responses

Question Question Question Question Question
1
2
3
4
5

Question
6

Responses

Participant
#1

Yes

Yes

No

Yes

Yes
-Provider
routine,
cost of
drugs, the
time
needed for
preoperative
treatment.

-Much
needed!

Participant
#2

Yes

Yes

No

Yes

No

-It will
benefit more
pediatric age
ranges.
Thank you.

Participant
#3

Yes

Yes

No

Yes

No

-This is
probably
outside the
scope of this
research
project,
however, if
one
technique
demonstrated
superiority in
decreasing
postoperative
recovery
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time (time
from
anesthesia
emergence
until
discharge
from the
facility), I
think more
anesthetists
would be
willing to
change their
practice
from the
traditional
approach.
This could
provide a
means to
decrease the
overall cost
and
improve
patient
satisfaction
scores.

Participant
#4

Yes

Yes

-

Yes

Yes

-

Participant
#5

Yes

Yes

No

Yes

No

-
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APPENDIX E – Best-Practice Guideline

BEST-PRACTICE GUIDELINE FOR REDUCING THE INCIDENCE OF PEDIATRIC
EMERGENCE AGITATION
This Guideline is aimed at preventing the incidence of pediatric emergence agitation. Review of
literature suggests several recommendations which demonstrate varying levels of success.
Premedication
Premedication goal is to provide sedation and anxiolysis prior to induction of anesthesia.
The three medications recommended for use are:
• Dexmedetomidine – Studies suggest dexmedetomidine provides sufficient anxiolysis
and sedation for pediatric patients prior to induction with minimal risk of respiratory
compromise. Recommended dosing for pediatric patients prior to induction is (PO- 1-4.2
mcg/kg) (Cote, Lerman, & Anderson, 2019).
• Midazolam – Research demonstrates several discrepancies regarding the administration
of midazolam and its effects on preventing the incidence of pediatric EA. Recommended
dosing for pediatric patients prior to induction is (PO- 0.25-0.75 mg/kg) (Cote, Lerman,
& Anderson, 2019).
• Clonidine – Review of research shows that clonidine provides excellent sedation as well
as prolonged analgesia following surgery. However, administration of clonidine should
occur at least one hour prior to induction, and may not be preferred in busy settings.
Recommended dosing prior to anesthetic induction is ( PO- 4 mcg/kg) (Cote, Lerman, &
Anderson, 2019).
Intraoperative Interventions
• Methods of Anesthesia – The use of inhalational anesthetics has been shown to
significantly increase the incidence of pediatric EA. Therefore, the recommended
anesthetic technique is to reduce the percentage of inhalational anesthetic administered.
This should be accomplished in two ways:
o TIVA following Inhalational Induction – Following anesthetic induction,
maintenance anesthesia will be achieved via propofol TIVA (Lerman & JÖhr,
2009).
o TIVA/Inhalational Anesthetic Hybrid (50/50) – Following anesthetic
inhalational induction, maintenance anesthesia will be achieved using low
percentage inhalational anesthetic with supplemental IV bolus doses of propofol
(1-2 mg/kg) or dexmedetomidine (0.2-0.3 mcg/kg) (Key, et al., 2010).
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